Merck KGaA MRK
News
Merck KGaA FY24 Outlook Improves After Strong Second Quarter
Germany's Merck to Sell Surface Solutions Unit For $721 Million
Germany's Merck to Buy Unity-SC for at Least $170 Million
German Stocks Fall Tuesday
Germany's Merck Group shares drop 10% after scrapping trial of promising cancer drug
Merck KGaA Shares Drop After Canceled Late-Stage Cancer Drug Study
Merck KGaA Signs Korea Science Research Pact
Merck KGaA Buys Mirus Bio for $600 Million
Merck KGaA Confirms Outlook After Drop in Sales, Earnings
Merck KGaA to Open $326 Million Pharmaceutical Plant in South Korea to Expand in Asia
Merck KGaA Expects Organic Sales, Earnings Growth This Year
Merck KGaA Supervisory Board Elects Michael Kleinemeier as Chair Until Annual Meeting
Merck KGaA Supervisory Board Chairman Wolfgang Buechele to Step Down
German stocks rise after ending at a record high
Trending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials
Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials
Merck MS Drug Fails to Meet Target of Late-Stage Trials
Merck to Pay at Least $70 Million for Rights to Abbisko Joint-Tumor Drug
Merck KGaA Sees Earnings, Sales at Lower Half of Outlook Ranges